Develops universal cell therapies using engineered iNKT cells from stem cells to create accessible, off-the-shelf treatments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Appia Bio is a biotechnology company focused on developing universal allogeneic cell therapies by engineering invariant natural killer T (iNKT) cells derived from hematopoietic stem cells. Their ACUA platform aims to create off-the-shelf treatments that are both scalable and accessible for patients.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Appia Bio Management Team
Appia Bio Valuations & Financials
View real-time NPM data on Appia Bio stock including daily Appia Bio stock price estimates, valuation history, and historical share price information. Access Appia Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Appia Bio pricing across six independent market signals. Looking for private company due diligence data sources on Appia Bio? Get in touch to learn more.
Similar Companies
like Appia Bio
Certify
Healthcare & Life Sciences
Automating provider network management that validates credentials, licenses, enrollment, and compliance via seamless API-driven workflows.
BEKHealth
Healthcare & Life Sciences
Leverages AI to sift through medical records and precisely match patients to clinical trials, speeding up recruitment.
Redox
Healthcare & Life Sciences
Provides a standardized API platform that enables seamless real-time data exchange across diverse healthcare systems.
Cortica
Healthcare & Life Sciences
Delivers comprehensive healthcare and therapy services for children with autism and developmental conditions through integrated medical support.
ONL Therapeutics
Healthcare & Life Sciences
Biopharmaceutical company develops innovative treatments to preserve vision by targeting cell death mechanisms in retinal diseases.
Curavit
Healthcare & Life Sciences
Fully virtual, patient-focused clinical trials with flexible operations and real-time digital integration.
Trellis Health
Healthcare & Life Sciences
Digital platform providing personalized pregnancy and postpartum care tools that simplify health tracking and deliver tailored insights for women.
Mandolin
Healthcare & Life Sciences
Automates healthcare specialty drug workflows that handle document intake, benefits checks, and authorization tasks to streamline clinical operations.
Medsien
Healthcare & Life Sciences
Enables remote patient monitoring and care management through AI-driven workflows and connected health data.
FAQ
We have answers
Appia Bio stock does not trade on public stock exchanges. Appia Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Appia Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Appia Bio Stock does not trade on public stock exchanges. In order to sell Appia Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Appia Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Appia Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Appia Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Appia Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Appia Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Appia Bio is a private company and has not had an IPO. There is currently no Appia Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Appia Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
